Preventing post-surgical abdominal adhesions: virtual presentation on palisade bio's lb1148 clinical data; to be hosted & moderated by stonegate capital partners

Dallas, texas--(newsfile corp. - march 14, 2022) - stonegate capital partners is hosting a webcast for palisade bio (nasdaq: pali) to discuss clinical data on lb1148, an investigational treatment of post-surgical abdominal adhesions. the virtual presentation will review the company's data being presented at the sages 2022 annual meeting and the need for new pharmaceutical options to prevent post-surgical...
PALI Ratings Summary
PALI Quant Ranking